Veradigm (MDRX) Competitors $4.68 -0.07 (-1.47%) As of 08/7/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock MDRX vs. OMCL, HSTM, CRTX, CNGL, OMQS, KBNT, BLIV, DAIC, SAIC, and RAMPShould you be buying Veradigm stock or one of its competitors? The main competitors of Veradigm include Omnicell (OMCL), HealthStream (HSTM), Cortexyme (CRTX), Canna-Global Acquisition (CNGL), OMNIQ (OMQS), Kubient (KBNT), Belive (BLIV), CID Holdco (DAIC), Science Applications International (SAIC), and LiveRamp (RAMP). Veradigm vs. Its Competitors Omnicell HealthStream Cortexyme Canna-Global Acquisition OMNIQ Kubient Belive CID Holdco Science Applications International LiveRamp Veradigm (NASDAQ:MDRX) and Omnicell (NASDAQ:OMCL) are both small-cap health care technology companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation. Does the media refer more to MDRX or OMCL? In the previous week, Omnicell had 10 more articles in the media than Veradigm. MarketBeat recorded 11 mentions for Omnicell and 1 mentions for Veradigm. Omnicell's average media sentiment score of 0.60 beat Veradigm's score of 0.00 indicating that Omnicell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veradigm 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Omnicell 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is MDRX or OMCL more profitable? Omnicell has a net margin of 2.01% compared to Veradigm's net margin of 0.00%. Omnicell's return on equity of 4.27% beat Veradigm's return on equity.Company Net Margins Return on Equity Return on Assets VeradigmN/A N/A N/A Omnicell 2.01%4.27%2.44% Do institutionals & insiders hold more shares of MDRX or OMCL? 97.7% of Omnicell shares are owned by institutional investors. 2.3% of Veradigm shares are owned by company insiders. Comparatively, 2.5% of Omnicell shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, MDRX or OMCL? Omnicell has lower revenue, but higher earnings than Veradigm. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeradigm$1.53B0.33N/AN/AN/AOmnicell$1.11B1.31$12.53M$0.5062.06 Which has more risk & volatility, MDRX or OMCL? Veradigm has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Do analysts rate MDRX or OMCL? Veradigm presently has a consensus price target of $13.00, suggesting a potential upside of 177.78%. Omnicell has a consensus price target of $45.33, suggesting a potential upside of 46.10%. Given Veradigm's higher possible upside, analysts plainly believe Veradigm is more favorable than Omnicell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veradigm 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Omnicell 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 SummaryOmnicell beats Veradigm on 11 of the 13 factors compared between the two stocks. Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDRX vs. The Competition Export to ExcelMetricVeradigmComputer integrated systems design IndustryBusiness SectorNASDAQ ExchangeMarket Cap$506.68M$1.21B$20.73B$9.57BDividend YieldN/A2.65%2.83%4.18%P/E RatioN/A1.9627.4525.14Price / Sales0.330.3667.36103.02Price / CashN/A9.4428.1858.58Price / BookN/A3.395.655.59Net IncomeN/A$223.79M$197.12M$265.48M7 Day Performance-3.51%3.25%1.71%1.22%1 Month Performance11.16%-0.62%-2.69%0.39%1 Year Performance-48.85%-5.23%33.77%23.47% Veradigm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDRXVeradigm2.1747 of 5 stars$4.68-1.5%$13.00+177.8%-49.8%$506.68M$1.53B0.008,000Positive NewsOMCLOmnicell3.6103 of 5 stars$30.42+2.2%$45.33+49.0%-20.5%$1.39B$1.11B60.843,670Earnings ReportHSTMHealthStream4.3559 of 5 stars$26.05+1.6%$31.50+20.9%-6.7%$782.97M$291.65M41.351,093News CoverageEarnings ReportDividend AnnouncementAnalyst ForecastCRTXCortexymeN/A$1.68-0.6%N/A+140.6%$50.65MN/A-0.5755CNGLCanna-Global AcquisitionN/A$10.74flatN/AN/A$70.99MN/A0.002OMQSOMNIQN/A$0.10flatN/A-41.3%$1.02M$81.19M-0.04190Gap UpKBNTKubientN/AN/AN/A-50.0%$1K$1.17M0.0040BLIVBeliveN/A$2.53+7.7%N/AN/A$0.00$1.85M0.0034Gap UpDAICCID HoldcoN/A$5.30+12.3%N/AN/A$0.00$290.47K0.00N/ASAICScience Applications International3.1434 of 5 stars$113.21+2.2%$125.64+11.0%-2.6%$5.31B$7.51B19.0926,000Positive NewsRAMPLiveRamp4.7022 of 5 stars$32.56+1.8%$41.29+26.8%+3.2%$2.08B$745.58M-3,256.401,300Trending NewsEarnings ReportAnalyst ForecastGap Down Related Companies and Tools Related Companies Omnicell Competitors HealthStream Competitors Cortexyme Competitors Canna-Global Acquisition Competitors OMNIQ Competitors Kubient Competitors Belive Competitors CID Holdco Competitors Science Applications International Competitors LiveRamp Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDRX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.